Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "A Ph1 Trial of Dose-Adjusted EPOCH + Inotuzumab Ozogamicin in Adults With R/R B-ALL"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Noam Kopmar
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Noam Kopmar
131 views
June 14, 2023
Comments 0
Login to view comments.
Click here to Login
Hematology